Related references
Note: Only part of the references are listed.Relationship of Plasma N- terminal Pro- brain Natriuretic Peptide Concentrations to Heart Failure Classification and Cause of Respiratory Distress in Dogs Using a 2nd Generation ELISA Assay
P. R. Fox et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2015)
Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels
Hai-Yan Pan et al.
BMC CARDIOVASCULAR DISORDERS (2014)
Effect of Nicorandil in Patients with Heart Failure: A Systematic Review and Meta-Analysis
Fujie Zhao et al.
CARDIOVASCULAR THERAPEUTICS (2014)
Heart Disease and Stroke Statistics-2014 Update A Report From the American Heart Association
Alan S. Go et al.
CIRCULATION (2014)
Dobutamine-induced changes of multidimensional cardiac deformation predict functional capacity in patients with advanced systolic heart failure
Ioannis A. Paraskevaidis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Conventional Hemodynamic Resuscitation May Fail to Optimize Tissue Perfusion: An Observational Study on the Effects of Dobutamine, Enoximone, and Norepinephrine in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
Corstiaan A. den Uil et al.
PLOS ONE (2014)
Epidemiology of Heart Failure
Veronique L. Roger
CIRCULATION RESEARCH (2013)
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
Sarah Mangiafico et al.
EUROPEAN HEART JOURNAL (2013)
Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo
Jichun Wang et al.
JOURNAL OF SURGICAL RESEARCH (2013)
The effects of levosimendan and dobutamine in experimental bupivacaine-induced cardiotoxicity
Ulku Kandemir et al.
BMC ANESTHESIOLOGY (2013)
Acute Decompensated Heart Failure
Jennifer R. Brown et al.
CARDIOLOGY CLINICS (2012)
Association of Smoking, Sleep Apnea, and Plasma Alkalosis With Nocturnal Ventricular Arrhythmias in Men With Systolic Heart Failure
Shahrokh Javaheri et al.
CHEST (2012)
The human sympathetic nervous system: its relevance in hypertension and heart failure
Gianfranco Parati et al.
EUROPEAN HEART JOURNAL (2012)
Recombinant B-type Natriuretic Peptide Nesiritide Attenuates Vascular Remodelling by Reducing Plasma Aldosterone in Rabbits
Shu-Qin Liu et al.
HEART LUNG AND CIRCULATION (2012)
Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials
Catherine L. Tacon et al.
INTENSIVE CARE MEDICINE (2012)
Hospital Patterns of Use of Positive Inotropic Agents in Patients With Heart Failure
Chohreh Partovian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Sustained Blood Pressure-Lowering Actions of Subcutaneous B-Type Natriuretic Peptide (Nesiritide) in a Patient With Uncontrolled Hypertension
Alessandro Cataliotti et al.
MAYO CLINIC PROCEEDINGS (2012)
Comentarios a la guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012. Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología
Manuel Anguita et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2012)
Fluid Overload Assessment and Management in Heart Failure Patients
Tertius Tuy et al.
SEMINARS IN NEPHROLOGY (2012)
Natriuretic peptide drug leads from snake venom
S. Vink et al.
TOXICON (2012)
Clinical development of pharmacologic agents for acute heart failure syndromes: A proposal for a mechanistic translational phase
Mihai Gheorghiade et al.
AMERICAN HEART JOURNAL (2011)
Chronic Heart Failure Current Evidence, Challenges to Therapy, and Future Directions
Ryan P. Morrissey et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2011)
Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study
Bruno Levy et al.
CRITICAL CARE MEDICINE (2011)
Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation
Deborah M. Dickey et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Epidemiology and risk profile of heart failure
Anh L. Bui et al.
NATURE REVIEWS CARDIOLOGY (2011)
Nesiritide in Acute Decompensated Heart Failure
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
C. M. O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
Claes-Hakan Bergh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction
Qiang Zhao et al.
HEART AND VESSELS (2010)
Trends in Length of Stay and Short-term Outcomes Among Medicare Patients Hospitalized for Heart Failure, 1993-2006
Hector Bueno et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Roles of atrial natriuretic peptide and its therapeutic use
Yoshihiko Saito
JOURNAL OF CARDIOLOGY (2010)
B-Type Natriuretic Peptide Pretreatment Attenuates Heart Ischemia-Reperfusion Injury in Rats
B. Ren et al.
TRANSPLANTATION PROCEEDINGS (2010)
Current drugs and medical treatment algorithms in the management of acute decompensated heart failure
Filippos Triposkiadis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
Stephen F. Jencks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Heart failure incidence and survival (from the atherosclerosis risk in communities study)
Laura R. Loehr et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Kenneth Dickstein et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure
Lindsay M. Arnold et al.
PHARMACOTHERAPY (2006)
Comparison of two methods to detect publication bias in meta-analysis
JL Peters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure
T Gerhard et al.
PHARMACOTHERAPY (2006)
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
SA Hunt et al.
CIRCULATION (2005)
HEGESMA: genome search meta-analysis and heterogeneity testing
E Zintzaras et al.
BIOINFORMATICS (2005)
Detrimental effects after dobutamine infusion on rat left ventricular function: mechanical work and energetics
C Nakajima-Takenaka et al.
EXPERIMENTAL PHYSIOLOGY (2005)
Heterogeneity testing in meta-analysis of genome searches
E Zintzaras et al.
GENETIC EPIDEMIOLOGY (2005)
Economic implications of Nesiritide versus Dobutamine in the treatment of patients with acutely decompensated congestive heart failure
G de Lissovoy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure
MA Silver et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Share Paper
